Salter Brothers Emerging Companies Ltd. · ASX:SB2
Salter Brothers Emerging Companies — Investor Presentation (February 2025)
11 slides from Salter Brothers Emerging Companies's investor presentation, Feb 11, 2025
Slide 1: Salter Brothers Emerging Companies Limited (ASX: SB2)
For personal use only SALTER BROTHERS EMERGING COMPANIES LIMITED (ASX CODE: SB2) FEBRUARY 2025 J U N E 202 3
Slide 2: Disclaimer
DISCLAIMER Important – General information and disclaimer is subject to change without notice. Past performance is provided Any investment contemplated by this document, including investment This information contained in this document has been prepared for illustrative purposes only and should not b
Slide 3: Contents
CONTENTS 1. Executive Summary For personal use only 2. 2024 Equity Markets Review 3. SB2 2024 Portfolio Performance 4. Key Market Drivers 5. 2025 Small Cap Outlook 6. SB2 Portfolio Positioning 7. Q&A S A LT E R B R O T H E R S | E M E R G I N G C O M PA N I E S L I M I T E D | F E B R U A R Y 2 0 2
Slide 4: 1. Executive Summary
1. EXECUTIVE SUMMARY › Salter Brothers is a global fund manager with over A$4B of group assets under management. For personal use only › Salter Brothers Emerging Companies Limited (ASX–SB2) is a listed investment company (LIC) dedicated to investing in small cap Australian companies with a market ca
Slide 5: 2. 2024 Equity Markets in Review
2. 2024 EQUITY MARKETS IN REVIEW Salter Brothers NTA vs Indexes 12 Salter Brothers NTA vs Indexes Performance Summary# Months 135 SB2 (Portfolio) 29% For personal use only 130 NTA SB2 Outperformance 125 S&P 500 22% to XEC 120 ASX:SB2 (Share Price) 50% Russell 2000 115 XEC ASX:SB2 Outperformance 43%
Slide 6: 3. SB2 2024 Portfolio Performance
3. SB2 2024 PORTFOLIO PERFORMANCE Top 3 Listed Contributors Key Positions Exited 1. ASX: AIM - Ai-Media Technologies › ASX: TEA - Tasmea For personal use only 2. ASX: AAL - Alfabs Australia › ASX: RUL - Rpmglobal Holdings 3. ASX: SPZ - Smart Parking › ASX: SPZ - Smart Parking › ASX: PBP - Probiotec
Slide 7: 4. Key Market Drivers
4. KEY MARKET DRIVERS DOMESTIC GLOBAL For personal use only Election Geopolitics Interest Rates Trade Wars Consumer Sentiment Interest Rates Exchange Rate Black Swan Event S A LT E R B R O T H E R S | E M E R G I N G C O M PA N I E S L I M I T E D | F E B R U A R Y 2 0 2 5 7
Slide 8: 5. 2025 Small Cap Outlook
5. 2025 SMALL CAP OUTLOOK Superior Future earnings growth (EPSg) For personal use only S A LT E R B R O T H E R S | E M E R G I N G C O M PA N I E S L I M I T E D | F E B R U A R Y 2 0 2 5 8
Slide 9: 6. SB2 Portfolio Positioning
6. SB2 PORTFOLIO POSITIONING Key Holdings Market Cap Sector Company Description 1. Botanix Pharmaceuticals Botanix’s experienced executive team has commenced commercialisation, with a fully trained and $840m Biotech Limited (ASX:BOT) certified sales force now in the field, driving adoption of Sofdra
Slide 10: Q&A
For personal use only Q&A Q&A S A LT E R B R O T H E R S | E M E R G I N G C O M PA N I E S L I M I T E D | F E B R U A R Y 2 0 2 5 1 0
Slide 11: Contact Us
CONTACT US Gregg Taylor For personal use only Investment Director & Head of Equities E | gregg.taylor@salterbrothers.com.au Yossi Kraemer Co‑head Capital Partnerships & Director Funds Management E | yossi.kraemer@salterbrothers.com.au P | 03 9258 2100 E | info@salterbrothersemergingcompanies.com.au
Salter Brothers Emerging Companies — Investor Presentation (February 2025) on 6ix